EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Occidiofungin inhibition of Candida biofilm formation on silicone elastomer surface

Rabina Kumpakha, Donna M Gordon iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02460-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Rabina Kumpakha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Mississippi State University , Mississippi State, Mississippi, USA. Hauptthemen laut MEDLINE: Candida, Antifungal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilms are the leading cause of clinically acquired fungal infections and contribute to significantly high morbidity and mortality in immunocompromised and hospitalized patients. Candida biofilms exhibit increased resistance to currently available antifungal agents that contribute to persistent reoccurring infections and are driving efforts to identify novel fungicidal compounds. The natural product, occidiofungin, is an antifungal compound with demonstrated activity against hyphal morphogenesis in polymorphic Candida species. In this study, we use an in vitro static biofilm model to demonstrate the efficacy of occidiofungin against C. albicans and C. tropicalis at all stages of biofilm development, including inhibiting cell dispersal. Consistent with prior findings, we demonstrate that actin organization is altered following occidiofungin exposure to include loss of F-actin cables and accumulation of actin aggregates. Altogether, our results provide strong evidence of the antibiofilm activity of occidiofungin toward Candida biofilms and support its potential as a therapeutic for Candida infections. IMPORTANCE Candida are opportunistic fungal pathogens with medical relevance given their association with superficial to life-threatening infections. An important component of Candida virulence is the ability to form a biofilm. These structures are highly resistant to antifungal therapies and are often the cause of treatment failure. In this work, we evaluated the efficacy of the antifungal compound, occidiofungin, against Candida biofilms developed on a silicone surface. We demonstrate that occidiofungin eliminated cells at all stages of biofilm formation in a dose-dependent manner. Consistent with our understanding of occidiofungin bioactivity, we noted alterations to actin organization and cell morphology following antifungal exposure. Given the challenges associated with the treatment of biofilm-associated infections, occidiofungin exhibits potential as a therapeutic antifungal agent in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CandidaAntifungal AgentsCandida albicansSilicone ElastomersBiofilmsMicrobial Sensitivity TestsGlycopeptidesPeptides, Cyclic

Stichwörter der Autor:innen

Candida albicansCandida tropicalisantifungal agentsbiofilms

Substanzen

Antifungal AgentsSilicone ElastomersoccidiofunginGlycopeptidesPeptides, Cyclic

Autor:innen und Institutionen

  • Department of Biological Sciences, Mississippi State University , Mississippi State, Mississippi, USA.

ORCID-Profile: Donna M Gordon

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Kumpakha, R., & Gordon, D. M. (2023). Occidiofungin inhibition of Candida biofilm formation on silicone elastomer surface. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02460-23

Vancouver

Kumpakha R, Gordon DM. Occidiofungin inhibition of Candida biofilm formation on silicone elastomer surface. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02460-23

BibTeX
@article{Kumpakha2023,
  author = {Kumpakha, Rabina and Gordon, Donna M},
  title = {Occidiofungin inhibition of Candida biofilm formation on silicone elastomer surface},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02460-23}
}
Kostenlos starten →